The story of the Cell and Gene Therapy Catapult in China

China is increasingly a global focus point for new medicines development. China will soon overtake the US to become the largest investor in scientific research and development in the world.

Jacqueline Barry, Chief Clinical Officer

I joined the Catapult’s first trip to China in 2017 and in March of this year, four of my colleagues returned, spending a week exploring Shanghai, Wuxi, Suzhou and Beijing. Our impression of China has been immensely positive. The quality of the scientific research is very high and we have met scientists and companies willing to share their data and who are open to collaboration. We’ve also been overwhelmed by the scale of China – the size of the cities, the hospitals and even the generosity from our hosts!